Skip to main content
Publish date:

Jim Cramer Says J&J's Quarter Wasn't That Bad, but He Can't Jump on Pharma Stocks Right Now

Jim Cramer thought Johnson & Johnson's results were decent but he remains cautious on pharma.

TheStreet's Jim Cramer says Johnson & Johnson's  (JNJ) - Get Johnson & Johnson (JNJ) Report  results weren't bad, but he's still cautious on pharma stocks given the political environment.

TheStreet Recommends